As mentioned in the Jonathan Goodman post, republishing this post-mortem of my investment in Knight Therapeutics will provide additional context for my thoughts about it currently.
Thanks Max. I think the only old Knight article I have access to is this one, and a very very bad first article I wrote. Trust me, that one would do you no good to read. I'm hoping that the newest article I wrote can serve as a timely alternative to those old articles.
thank you very much for this postmortem. I loved reading it. I hope you will post your old articles about Knight on Substack
Thanks Max. I think the only old Knight article I have access to is this one, and a very very bad first article I wrote. Trust me, that one would do you no good to read. I'm hoping that the newest article I wrote can serve as a timely alternative to those old articles.